Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection

Journal of Infectious Diseases

Volumn 193, Issue 4, 2006, Pages 591-597

  Bravo, Fernando J ^a   Cardin, Rhonda D ^a   Bernstein, David I ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; PLACEBO; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA EXTRACTION; DRUG EFFECT; DRUG SAFETY; FEMALE; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GUINEA PIG; INFECTION PREVENTION; INOCULATION; LIVER; MATERNAL TREATMENT; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY; SINGLE DRUG DOSE; SPLEEN; SURVIVAL RATE; VIREMIA; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANIMALS, NEWBORN; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOSINE; DISEASE MODELS, ANIMAL; DISEASE TRANSMISSION, VERTICAL; FEMALE; GUINEA PIGS; IMMUNITY, MATERNALLY-ACQUIRED; ORGANOPHOSPHORUS COMPOUNDS; PREGNANCY; PREGNANCY OUTCOME; VIRUS REPLICATION;

EID: 32044464075     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/499603     Document Type: Article

References (40)

1. Pass RF. Cytomegalovirus. In: Knipe DM, Howley PM, Griffin DE, et al., eds. Fields virology. 4th ed. Vol 2. Philadelphia: Lippincott, Williams & Wilkins, 2001:2675-705.
2. Nelson CT, Demmler GJ. Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clin Perinatol 1997; 24:151-60.
3. Freij BJ, Sever JL. Herpesvirus infections in pregnancy: risks to embryo, fetus, and neonate. Clin Perinatol 1988; 15:203-31.
4. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002; 57:245-56.
5. Pass RF, Stagno S, Myers GJ, Alford CA. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 1980; 66:758-62.
6. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997; 130:624-30.
7. Ivarsson SA, Lernmark B, Svanberg L. Ten-year clinical, developmental, and intellectual follow-up of children with congenital cytomegalovirus infection without neurologic symptoms at one year of age. Pediatrics 1997; 99:800-3.
8. Kimberlin DW, Lin CY, Sanchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003; 143:16-25.
9. Griffiths PD. Strategies to prevent CMV infection in the neonate. Semin Neonatol 2002; 7:293-9.
10. Lazzarotto T, Gabrielli L, Lanari M, et al. Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection. Hum Immunol 2004; 65:410-5.
11. Lazzarotto T, Varani S, Spezzacatena P, et al. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol 2000; 13:137-41.
12. Maine GT, Stricker R, Schuler M, et al. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J Clin Microbiol 2000; 38:1476-81.
13. Nigro G, Anceschi MM, Cosmi EV, Congenital Cytomegalic Disease Collaborating Group. Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection. BJOG 2003; 110:572-7
14. Revello M, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15:680-715.
15. Jones RN, Neale ML, Beattie B, Westmoreland D, Fox JD. Development and application of a PCR-based method including an internal control for diagnosis of congenital cytomegalovirus infection. J Clin Microbiol 2000; 38:1-6.
16. Bratcher DF, Bourne N, Bravo FJ, et al. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J Infect Dis 1995; 172:944-50.
17. Bia FJ, Griffith BP, Fong CK, Hsiung GD. Cytomegaloviral infections in the guinea pig: experimental models for human disease. Rev Infect Dis 1983; 5:177-95.
18. Kumar ML, Nankervis GA. Experimental congenital infection with cytomegalovirus: a guinea pig model. J Infect Dis 1978; 138:650-4.
19. Harrison CJ, Britt WJ, Chapman NM, Mullican J, Tracy S. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model. J Infect Dis 1995; 172:1212-20.
20. Yang H, Datema R. Prolonged and potent therapeutic and prophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]cytosine against herpes simplex virus type 2 infections in mice. Antimicrob Agents Chemother 1991; 35:1596-600.
21. Cundy KC, Bidgood AM, Lynch G, Shaw JP, Griffin L, Lee WA. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats. Drug Metab Dispos 1996; 24:745-52.
22. Cundy KC, Lynch G, Shaw JP, Hitchcock MJ, Lee WA. Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits. Curr Eye Res 1996; 15:569-76.
23. Cundy KC, Barditch-Crovo P, Petty BG, et al. Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 1999; 43:271-7.
24. Harrison CJ, Myers MG. Peripheral blood mononuclear cell-mediated cytolytic activity during cytomegalovirus (CMV) infection of guinea pigs. J Med Virol 1988; 25:441-53.
25. Bourne N, Bravo FJ, Bernstein DI. Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals. Antiviral Res 2000; 47:103-9.
26. Fox DS, Schleiss MR. Sequence and transcriptional analysis of the guinea pig cytomegalovirus UL97 homolog. Virus Genes 1997; 15:255-64.
27. Bernstein DI, Bourne N. Animal models for cytomegalovirus infection: guinea-pig CMV. In: Zak O, Sande MA, eds. Handbook of animal models of infection. San Diego: Academic Press, 1999:935-41.
28. Schleiss MR, McVoy MA. Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. Expert Rev Anti Infect Ther 2004; 2:389-402.
29. Pescovitz MD. Absence of teratogenicity of oral ganciclovir used during early pregnancy in a liver transplant recipient. Transplantation 1999; 67:758-9.
30. Miller BW, Howard TK, Goss JA, Mostello DJ, Holcomb WL Jr, Brennan DC. Renal transplantation one week after conception. Transplantation 1995; 60:1353-4.
31. Nigro G, La Torre R, Anceschi MM, Mazzocco M, Cosmi EV. Hyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction. Am J Obstet Gynecol 1999; 180:1222-6.
32. Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalic Disease Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005; 353:1350-62.
33. Wheat RL, Clark PY, Brown MG. Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR. J Virol Methods 2003; 112:107-13.
34. Revello MG, Sarasini A, Zavattoni M, Baldanti F, Gerna G. Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction. J Med Virol 1998; 56: 99-103.
35. Hayes K, Gibas H. Placental cytomegalovirus infection without fetal involvement following primary infection in pregnancy. J Pediatr 1971; 79:401-5.
36. Griffiths PD, Baboonian C. A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol 1984; 91:307-15.
37. Fisher S, Genbacev O, Maidji E, Pereira L. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 2000; 74:6808-20.
38. Fisher SJ. The placenta dilemma. Semin Reprod Med 2000; 18:321-6.
39. Cruz Spano L, Lima Pereira FE, Gomes da Silva Basso N, Mercon-de-Vargas PR. Human cytomegalovirus infection and abortion: an immunohistochemical study. Med Sci Monit 2002; 8:BR230-5.
40. Griffith BP, McCormick SR, Fong CK, Lavallee JT, Lucia HL, Goff E. The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol 1985; 55:402-9.